2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices
BACKGROUND: Arterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension. With the emergence of new devices for assessing PWV, it has become evident that some of these devices yield results that display significant discrepancies compared with previous devices. This discrepancy underscores the importance of comprehensive validation procedures and the need for international recommendations.
METHODS: A stepwise approach utilizing the modified Delphi technique, with the involvement of key scientific societies dedicated to arterial stiffness research worldwide, was adopted to formulate, through a multidisciplinary vision, a shared approach to the validation of noninvasive arterial PWV measurement devices.
RESULTS: A set of recommendations has been developed, which aim to provide guidance to clinicians, researchers, and device manufacturers regarding the validation of new PWV measurement devices. The intention behind these recommendations is to ensure that the validation process can be conducted in a rigorous and consistent manner and to promote standardization and harmonization among PWV devices, thereby facilitating their widespread adoption in clinical practice.
CONCLUSIONS: It is hoped that these recommendations will encourage both users and developers of PWV measurement devices to critically evaluate and validate their technologies, ultimately leading to improved consistency and comparability of results. This, in turn, will enhance the clinical utility of PWV as a valuable tool for assessing arterial stiffness and informing cardiovascular risk stratification and management in individuals with hypertension.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
|---|---|
| Enthalten in: |
Hypertension (Dallas, Tex. : 1979) - 81(2024), 1 vom: 15. Jan., Seite 183-192 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Aorta |
|---|
| Anmerkungen: |
Date Completed 22.12.2023 Date Revised 17.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/HYPERTENSIONAHA.123.21618 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364667869 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364667869 | ||
| 003 | DE-627 | ||
| 005 | 20240217232243.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/HYPERTENSIONAHA.123.21618 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1297.xml |
| 035 | |a (DE-627)NLM364667869 | ||
| 035 | |a (NLM)37975229 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Spronck, Bart |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2023 | ||
| 500 | |a Date Revised 17.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Arterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension. With the emergence of new devices for assessing PWV, it has become evident that some of these devices yield results that display significant discrepancies compared with previous devices. This discrepancy underscores the importance of comprehensive validation procedures and the need for international recommendations | ||
| 520 | |a METHODS: A stepwise approach utilizing the modified Delphi technique, with the involvement of key scientific societies dedicated to arterial stiffness research worldwide, was adopted to formulate, through a multidisciplinary vision, a shared approach to the validation of noninvasive arterial PWV measurement devices | ||
| 520 | |a RESULTS: A set of recommendations has been developed, which aim to provide guidance to clinicians, researchers, and device manufacturers regarding the validation of new PWV measurement devices. The intention behind these recommendations is to ensure that the validation process can be conducted in a rigorous and consistent manner and to promote standardization and harmonization among PWV devices, thereby facilitating their widespread adoption in clinical practice | ||
| 520 | |a CONCLUSIONS: It is hoped that these recommendations will encourage both users and developers of PWV measurement devices to critically evaluate and validate their technologies, ultimately leading to improved consistency and comparability of results. This, in turn, will enhance the clinical utility of PWV as a valuable tool for assessing arterial stiffness and informing cardiovascular risk stratification and management in individuals with hypertension | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a aorta | |
| 650 | 4 | |a cardiovascular diseases | |
| 650 | 4 | |a guideline | |
| 650 | 4 | |a methods | |
| 650 | 4 | |a pulse wave analysis | |
| 650 | 4 | |a vascular stiffness | |
| 700 | 1 | |a Terentes-Printzios, Dimitrios |e verfasserin |4 aut | |
| 700 | 1 | |a Avolio, Alberto P |e verfasserin |4 aut | |
| 700 | 1 | |a Boutouyrie, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Guala, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Jerončić, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Laurent, Stéphane |e verfasserin |4 aut | |
| 700 | 1 | |a Barbosa, Eduardo C D |e verfasserin |4 aut | |
| 700 | 1 | |a Baulmann, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Chen-Huan |e verfasserin |4 aut | |
| 700 | 1 | |a Chirinos, Julio A |e verfasserin |4 aut | |
| 700 | 1 | |a Daskalopoulou, Stella S |e verfasserin |4 aut | |
| 700 | 1 | |a Hughes, Alun D |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmud, Azra |e verfasserin |4 aut | |
| 700 | 1 | |a Mayer, Christopher C |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Jeong Bae |e verfasserin |4 aut | |
| 700 | 1 | |a Pierce, Gary L |e verfasserin |4 aut | |
| 700 | 1 | |a Schutte, Aletta E |e verfasserin |4 aut | |
| 700 | 1 | |a Urbina, Elaine M |e verfasserin |4 aut | |
| 700 | 1 | |a Wilkinson, Ian B |e verfasserin |4 aut | |
| 700 | 1 | |a Segers, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Sharman, James E |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Isabella |e verfasserin |4 aut | |
| 700 | 1 | |a Vlachopoulos, Charalambos |e verfasserin |4 aut | |
| 700 | 1 | |a Weber, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Bianchini, Elisabetta |e verfasserin |4 aut | |
| 700 | 1 | |a Bruno, Rosa Maria |e verfasserin |4 aut | |
| 700 | 0 | |a Association for Research into Arterial Structure and Physiology (ARTERY), the European Society of Hypertension Working Group on Large Arteries, European Cooperation in Science and Technology (COST) Action VascAgeNet, North American Artery Society, ARTERY LATAM, Pulse of Asia, and Society for Arterial Stiffness—Germany-Austria-Switzerland (DeGAG) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hypertension (Dallas, Tex. : 1979) |d 1983 |g 81(2024), 1 vom: 15. Jan., Seite 183-192 |w (DE-627)NLM000456136 |x 1524-4563 |7 nnns |
| 773 | 1 | 8 | |g volume:81 |g year:2024 |g number:1 |g day:15 |g month:01 |g pages:183-192 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/HYPERTENSIONAHA.123.21618 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 81 |j 2024 |e 1 |b 15 |c 01 |h 183-192 | ||